Astellas Pharma

Astellas Pharma Operating Metrics

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Astellas Pharma key operating metrics including Phase I Trials Products (Regeneration), environmental, and social and governance score (ESG).

Phase I Trials Products (Regeneration)

Oct, 2020

Phase I Trials Products (Antigen Specific Immunomodulation)

FY, 2020

Phase II Trials Products (Mitochondria)

Oct, 2020

Operating Metrics

Metrics	FY, 2020
Phase I Trials Products (Regeneration)	1
Phase I Trials Products (Antigen Specific Immunomodulation)	2
Phase II Trials Products (Mitochondria)	1
Phase I Trials Products (Mitochondria)	1
Phase II Trials Products (Genetic Regulation)	1
Phase I Trials Products (Genetic Regulation)	1
Phase I Trials Products (Immuno-Oncology)	5
Phase III Trials Products (Oncology)	4
Phase II Trials Products (Oncology)	1
Phase I Trials Products (Oncology)	1
Phase III Trials Products (Immunology)	1
Phase II Trials Products (Immunology)	1
Phase I Trials Products (Immunology)	1
Phase III Trials Products (Other)	1
Phase II Trials Products (Other)	2
Phase I Trials Products (Other)	1
Phase III Trials Products (Urology and Nephrology)	5
Phase II Trials Products (Urology and Nephrology)	2
Phase II Trials Products (Regeneration)	2

60-79 out of 100

Community

Employees

Environment

Governance

Premium Content only available in Craft’s Intelligence Portal

Source:CSRHub